Literature DB >> 6326665

Liquid chromatographic assay of ceftizoxime in sera of normal and uremic patients.

E M McCormick, R M Echols, T G Rosano.   

Abstract

The application of high-pressure liquid chromatography assays for cephalosporin serum concentrations is difficult in uremic patients because of interference from nondialyzable substances. We developed a high-pressure liquid chromatography method for determining the serum concentration of ceftizoxime in normal and uremic patients. The method involves protein precipitation with acetonitrile, followed by removal of the acetonitrile with dichloromethane. Separation was accomplished with a reverse-phase (C-18) column and a mobile phase of 13% acetonitrile and 2.8% acetic acid. UV detection at 310 nm was used to monitor the peaks. This assay produced a linear relationship between peak height ratio and ceftizoxime concentration from 1.5 to 100 micrograms/ml. Samples from 30 patients were assayed by this method and by a bioassay, with a good correlation of results (r = 0.9832). The method was applicable equally to normal and uremic serum samples.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6326665      PMCID: PMC185511          DOI: 10.1128/AAC.25.3.336

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  High-pressure liquid chromatographic assay of ceftizoxime with an anion-exchange extraction technique.

Authors:  C E Fasching; L R Peterson; K M Bettin; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

2.  Determination of apalcillin and its metabolites in human body fluids by high-pressure liquid chromatography.

Authors:  K Borner; H Lode; A Elvers
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

Review 3.  High-pressure liquid chromatography for quantitation of antimicrobial agents.

Authors:  T T Yoshikawa; S K Maitra; M C Schotz; L B Guze
Journal:  Rev Infect Dis       Date:  1980 Mar-Apr

4.  High-performance liquid chromatographic determination of ceftizoxime, a new cephalosporin antibiotic, in rat serum, bile and urine.

Authors:  A Suzuki; K Noda; H Noguchi
Journal:  J Chromatogr       Date:  1980-06-13

5.  Reversed-phase high-performance liquid chromatographic assay for cefoxitin in proteinaceous biological samples.

Authors:  M G Torchia; R G Danzinger
Journal:  J Chromatogr       Date:  1980-01-11

6.  Determination of cephalosporins in biological material by reversed-phase liquid column chromatography.

Authors:  A M Brisson; J B Fourtillan
Journal:  J Chromatogr       Date:  1981-05-08

7.  Peritoneal absorption of moxalactam.

Authors:  N M Stephens; N O Kronfol; B J Kline; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

8.  Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function.

Authors:  S F Kowalsky; R M Echols; A R Venezia; E A Andrews
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

  8 in total
  6 in total

1.  Recent analytical methods for cephalosporins in biological fluids.

Authors:  R D Toothaker; D S Wright; L A Pachla
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

2.  Crossover assessment of serum bactericidal activity and pharmacokinetics of five broad-spectrum cephalosporins in the elderly.

Authors:  R G Deeter; M P Weinstein; K A Swanson; J S Gross; L C Bailey
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

3.  Validation and Application of an LC-MS-MS Method for the Determination of Ceftizoxime in Human Serum and Urine.

Authors:  Lu Wang; Xin Zheng; Wen Zhong; Jia Chen; Ji Jiang; Pei Hu
Journal:  J Chromatogr Sci       Date:  2016-02-18       Impact factor: 1.618

4.  Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.

Authors:  H C Standiford; G L Drusano; A Forrest; B Tatem; K Plaisance
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

Review 6.  Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Richards; R C Heel
Journal:  Drugs       Date:  1985-04       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.